1. Home
  2. NVCR vs LEG Comparison

NVCR vs LEG Comparison

Compare NVCR & LEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • LEG
  • Stock Information
  • Founded
  • NVCR 2000
  • LEG 1883
  • Country
  • NVCR Switzerland
  • LEG United States
  • Employees
  • NVCR N/A
  • LEG N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • LEG Home Furnishings
  • Sector
  • NVCR Health Care
  • LEG Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • LEG Nasdaq
  • Market Cap
  • NVCR 1.4B
  • LEG 1.2B
  • IPO Year
  • NVCR 2015
  • LEG N/A
  • Fundamental
  • Price
  • NVCR $13.77
  • LEG $9.16
  • Analyst Decision
  • NVCR Buy
  • LEG Hold
  • Analyst Count
  • NVCR 7
  • LEG 4
  • Target Price
  • NVCR $28.79
  • LEG $10.50
  • AVG Volume (30 Days)
  • NVCR 1.6M
  • LEG 1.4M
  • Earning Date
  • NVCR 10-30-2025
  • LEG 10-27-2025
  • Dividend Yield
  • NVCR N/A
  • LEG 2.19%
  • EPS Growth
  • NVCR N/A
  • LEG N/A
  • EPS
  • NVCR N/A
  • LEG 1.02
  • Revenue
  • NVCR $630,160,000.00
  • LEG $4,238,200,000.00
  • Revenue This Year
  • NVCR $6.68
  • LEG N/A
  • Revenue Next Year
  • NVCR $7.01
  • LEG $0.46
  • P/E Ratio
  • NVCR N/A
  • LEG $8.93
  • Revenue Growth
  • NVCR 14.58
  • LEG N/A
  • 52 Week Low
  • NVCR $10.87
  • LEG $6.48
  • 52 Week High
  • NVCR $34.13
  • LEG $13.20
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 51.39
  • LEG 52.90
  • Support Level
  • NVCR $13.57
  • LEG $9.02
  • Resistance Level
  • NVCR $14.58
  • LEG $9.23
  • Average True Range (ATR)
  • NVCR 0.64
  • LEG 0.25
  • MACD
  • NVCR -0.05
  • LEG 0.07
  • Stochastic Oscillator
  • NVCR 49.59
  • LEG 74.29

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About LEG Leggett & Platt Incorporated

Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.

Share on Social Networks: